Harrow (HROW) EBITDA (2010 - 2026)
Harrow (HROW) posted EBITDA of -$11.0 million for Q2 2026, up 50.15% on a QoQ basis from -$22.1 million in Q1 2026, and down 196.48% year-over-year from $11.4 million in Q2 2025.
Analysis
Harrow (HROW) EBITDA (2010 - 2026) Analysis & Trends
Harrow has reported EBITDA for 17 years, with the latest figure at -$11.0 million in Q2 2026.
- On a quarterly basis, EBITDA fell 196.48% year-over-year to -$11.0 million in Q2 2026; TTM through Jun 2026 was -$2.7 million, a 119.09% decrease from a year earlier, with the FY2025 full-year figure at $30.5 million, up 245.9% from the prior year.
- EBITDA was -$11.0 million for Q2 2026 at Harrow, up from -$22.1 million in the prior quarter.
- The five-year high for EBITDA was $15.6 million in Q4 2025, with the low at -$22.1 million in Q1 2026.
- Average EBITDA over 5 years is $477777.8, with a median of $1.4 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2024: EBITDA soared 1955.32% in 2023, then sank 672.56% in 2024.
- Over 5 years, EBITDA stood at -$1.8 million in 2022, then plunged by 174.18% to -$4.9 million in 2023, then soared by 364.59% to $12.9 million in 2024, then rose by 20.87% to $15.6 million in 2025, then tumbled by 170.6% to -$11.0 million in 2026.
- The last three EBITDA figures came in at -$11.0 million (Q2 2026), -$22.1 million (Q1 2026), and $15.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 4.27 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 1.22 Bn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | -505.13 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 697.90 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 330.80 Mn |
| 10 | Harrow | 1.41 Bn | 1.32 Bn | 50.36 Mn | -11.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.01 Mn |
| Mar 31, 2026 | -22.08 Mn |
| Dec 31, 2025 | 15.59 Mn |
| Sep 30, 2025 | 14.75 Mn |
| Jun 30, 2025 | 11.41 Mn |
| Mar 31, 2025 | -11.23 Mn |
| Dec 31, 2024 | 12.90 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | -6.93 Mn |
| Dec 31, 2023 | -4.88 Mn |
| Sep 30, 2023 | 1.74 Mn |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Dec 31, 2022 | -1.78 Mn |
| Sep 30, 2022 | -94,000.00 |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | -1.76 Mn |
| Sep 30, 2021 | -3.72 Mn |